Drug pricing

News

Pharma in a spin as it tries to gauge Trump tariffs impact

Pharmaceuticals are exempt from the tariffs revealed by President Donald Trump, for now, but the industry is bracing for what may come next.

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

News

Santhera's DMD drug poised for wider rollout in Germany

Santhera has agreed pricing and reimbursement for its Duchenne muscular dystrophy drug Agamree with German health funds representing 90% of patients.

Market Access

NICE contribution to the cost per QALY threshold debate?

Leela Barham sets out some wider context to the latest blog from NICE on the cost-effectiveness threshold used by the agency and highlights the opportunity for stakeholders to build their c

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

News

Medicare price negotiations 'will continue under Trump'

President Trump will continue Medicare drug pricing negotiation but intends to look for improvements to the scheme according to CMS.

Pharma in a spin as it tries to gauge Trump tariffs impact

Pharma urges NHS to put medicines at heart of 10-year plan

Santhera's DMD drug poised for wider rollout in Germany

NICE contribution to the cost per QALY threshold debate?

Life Sciences Industry Report - Biologics and Generics

Medicare price negotiations 'will continue under Trump'

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Drug pricing

Editor's Picks